| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VASERETIC | 8MG 25MG | TABLET | Resolved | 2020-04-24 | 2020-05-26 | 113158 |
| VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
| VISKAZIDE | 25MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256268 |
| VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
| VISKAZIDE | 50MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256271 |
| ZESTORETIC | 25MG 20MG | TABLET | Actual shortage | 2026-02-05 | 2026-02-05 | 277421 |
| ZESTORETIC | 25MG 20MG | TABLET | Resolved | 2023-11-28 | 2026-01-08 | 211675 |
| ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2026-02-05 | 202917 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Resolved | 2023-09-15 | 2023-09-20 | 204548 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |